Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
Journal of Chemical Information and Computer Sciences|September 28, 2004
Evaluation of mutual information and genetic programming for feature selection in QSARVishwesh Venkatraman, Andrew Rowland Dalby, Zheng Rong Yang
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 9, 2014
Transporter-mediated uptake of UDP-glucuronic acid by human liver microsomes: assay conditions, kinetics, and inhibitionAndrew Rowland, Peter I Mackenzie, John O Miners
The International Journal of Biochemistry & Cell Biology|March 19, 2013
The UDP-glucuronosyltransferases: their role in drug metabolism and detoxificationAndrew Rowland, John O Miners, Peter I Mackenzie
Therapeutic Advances in Drug Safety|August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomesMichael J Sorich, Andrew Rowland, Michael D Wiese
Journal of Clinical Medicine|July 3, 2020
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseLauren A Newman, Michael J Sorich, Andrew Rowland
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2015
Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug InteractionsAttarat Pattanawongsa, Nuy Chau, Andrew Rowland, et al.
British Journal of Clinical Pharmacology|July 15, 2025
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?Christina Gao, Ashley M Hopkins, Andrew Rowland, et al.
International Journal of Clinical Oncology|May 18, 2020
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patientsWarit Ruanglertboon, Michael J Sorich, Andrew Rowland, et al.
European Journal of Clinical Pharmacology|May 5, 2017
Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio: could a drug-induced toxicity be regulating exposure to the offending agent?Andrew Rowland, Angela Rowland, Michael J Sorich, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme InhibitionAttarat Pattanawongsa, Pramod C Nair, Andrew Rowland, et al.
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
Journal of Chemical Information and Computer Sciences|September 28, 2004
Evaluation of mutual information and genetic programming for feature selection in QSARVishwesh Venkatraman, Andrew Rowland Dalby, Zheng Rong Yang
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 9, 2014
Transporter-mediated uptake of UDP-glucuronic acid by human liver microsomes: assay conditions, kinetics, and inhibitionAndrew Rowland, Peter I Mackenzie, John O Miners
The International Journal of Biochemistry & Cell Biology|March 19, 2013
The UDP-glucuronosyltransferases: their role in drug metabolism and detoxificationAndrew Rowland, John O Miners, Peter I Mackenzie
Therapeutic Advances in Drug Safety|August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomesMichael J Sorich, Andrew Rowland, Michael D Wiese
Journal of Clinical Medicine|July 3, 2020
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseLauren A Newman, Michael J Sorich, Andrew Rowland
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2015
Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug InteractionsAttarat Pattanawongsa, Nuy Chau, Andrew Rowland, et al.
British Journal of Clinical Pharmacology|July 15, 2025
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?Christina Gao, Ashley M Hopkins, Andrew Rowland, et al.
International Journal of Clinical Oncology|May 18, 2020
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patientsWarit Ruanglertboon, Michael J Sorich, Andrew Rowland, et al.
European Journal of Clinical Pharmacology|May 5, 2017
Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio: could a drug-induced toxicity be regulating exposure to the offending agent?Andrew Rowland, Angela Rowland, Michael J Sorich, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2015
Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme InhibitionAttarat Pattanawongsa, Pramod C Nair, Andrew Rowland, et al.
Pageof 19